Gritstone Bio: Gritstone bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024

Gritstone bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported revenue was USD 0.921 million compared to USD 1.96 million a year ago. Net loss was USD 23.4 million compared to USD 35.26 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.31 a year ago. Diluted loss per share from continuing operations was USD 0.16 compared to USD 0.31 a year ago. For the six months, revenue was USD 2.66 million compared to USD 4.4 million a year ago. Net loss was USD 63.78 million compared to USD 69.24 million a year ago. Basic loss per share from continuing operations was USD 0.49 compared to USD 0.6 a year ago. Diluted loss per share from continuing operations was USD 0.49 compared to USD 0.6 a year ago.